Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Endocrinol ; 178(4): 377-388, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29419413

ABSTRACT

OBJECTIVE: Congenital hypogonadotropic hypogonadism (CHH) and constitutional delay of growth and puberty (CDGP) represent rare and common forms of GnRH deficiency, respectively. Both CDGP and CHH present with delayed puberty, and the distinction between these two entities during early adolescence is challenging. More than 30 genes have been implicated in CHH, while the genetic basis of CDGP is poorly understood. DESIGN: We characterized and compared the genetic architectures of CHH and CDGP, to test the hypothesis of a shared genetic basis between these disorders. METHODS: Exome sequencing data were used to identify rare variants in known genes in CHH (n = 116), CDGP (n = 72) and control cohorts (n = 36 874 ExAC and n = 405 CoLaus). RESULTS: Mutations in at least one CHH gene were found in 51% of CHH probands, which is significantly higher than in CDGP (7%, P = 7.6 × 10-11) or controls (18%, P = 5.5 × 10-12). Similarly, oligogenicity (defined as mutations in more than one gene) was common in CHH patients (15%) relative to CDGP (1.4%, P = 0.002) and controls (2%, P = 6.4 × 10-7). CONCLUSIONS: Our data suggest that CDGP and CHH have distinct genetic profiles, and this finding may facilitate the differential diagnosis in patients presenting with delayed puberty.


Subject(s)
Growth Disorders/diagnosis , Growth Disorders/genetics , Hypogonadism/diagnosis , Hypogonadism/genetics , Puberty, Delayed/diagnosis , Puberty, Delayed/genetics , Adult , Aged , Cohort Studies , Female , Finland/epidemiology , Growth Disorders/epidemiology , Humans , Hypogonadism/epidemiology , Male , Middle Aged , Mutation/genetics , Puberty, Delayed/epidemiology
2.
BMC Syst Biol ; 7: 60, 2013 Jul 15.
Article in English | MEDLINE | ID: mdl-23856357

ABSTRACT

BACKGROUND: The development of ovarian follicles hinges on the timely exposure to the appropriate combination of hormones. Follicle stimulating hormone (FSH) and luteinizing hormone (LH) are both produced in the pituitary gland and are transported via the blood circulation to the thecal layer surrounding the follicle. From there both hormones are transported into the follicle by diffusion. FSH-receptors are expressed mainly in the granulosa while LH-receptors are expressed in a gradient with highest expression in the theca. How this spatial organization is achieved is not known. Equally it is not understood whether LH and FSH trigger distinct signalling programs or whether the distinct spatial localization of their G-protein coupled receptors is sufficient to convey their distinct biological function. RESULTS: We have developed a data-based computational model of the spatio-temporal signalling processes within the follicle and (i) predict that FSH and LH form a gradient inside the follicle, (ii) show that the spatial distribution of FSH- and LH-receptors can arise from the well known regulatory interactions, and (iii) find that the differential activity of FSH and LH may well result from the distinct spatial localisation of their receptors, even when both receptors respond with the same intracellular signalling cascade to their ligand. CONCLUSION: The model integrates the large amount of published data into a consistent framework that can now be used to better understand how observed defects translate into failed follicle maturation.


Subject(s)
Computer Simulation , Ovarian Follicle/growth & development , Androgens/blood , Androgens/metabolism , Animals , Biocatalysis , Cattle , Diffusion , Estradiol/biosynthesis , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Infertility/metabolism , Infertility/pathology , Infertility/physiopathology , Luteinizing Hormone/blood , Models, Biological , Ovarian Follicle/cytology , Ovarian Follicle/metabolism , Ovarian Follicle/pathology , Receptors, Estrogen/biosynthesis , Receptors, Somatomedin/biosynthesis , Receptors, Somatomedin/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...